Enamel matrix proteins in the regenerative therapy of deep intrabony defects. - Wikidata - awgldk - TriplyDB

Enamel matrix proteins in the regenerative therapy of deep intrabony defects.

Enamel matrix proteins in the regenerative therapy of deep intrabony defects.

http://www.wikidata.org/entity/Q40645337

about

Enamel matrix derivative (Emdogain®) for periodontal tissue regeneration in intrabony defects Minimally Invasive Surgery Combined with Regenerative Biomaterials in Treating Intra-Bony Defects: A Meta-Analysis Biologic Agents for Periodontal Regeneration and Implant Site Development Do the clinical effects of enamel matrix derivatives in infrabony defects decrease overtime? A systematic review and meta-analysis In vitro Osteogenic impulse effect of Dexamethasone on periodontal ligament stem cells.A minimally invasive surgical technique with an enamel matrix derivative in the regenerative treatment of intra-bony defects: a novel approach to limit morbidity.Single minimally invasive surgical technique with an enamel matrix derivative to treat multiple adjacent intra-bony defects: clinical outcomes and patient morbidity.Clinical performance of a regenerative strategy for intrabony defects: scientific evidence and clinical experience.Minimally invasive surgical technique and enamel matrix derivative in intra-bony defects. I: Clinical outcomes and morbidity.Clinical evaluation of periodontal surgical treatment with an Er:YAG laser: 5-year results.Clinical and radiographic outcomes of the modified minimally invasive surgical technique with and without regenerative materials: a randomized-controlled trial in intra-bony defects.Periodontal regenerative therapy with enamel matrix derivative in the treatment of intrabony defects: a prospective 2-year study Coronally advanced flap adjunct with low intensity laser therapy: a randomized controlled clinical pilot study.Periodontitis and systemic inflammation: control of the local infection is associated with a reduction in serum inflammatory markers.Two-year randomized clinical trial of enamel matrix derivative treated infrabony defects: radiographic analysis Treatment of intrabony periodontal defects with enamel matrix derivative: a literature review.A systematic review of graft materials and biological agents for periodontal intraosseous defects.Periodontal regeneration - intrabony defects: a systematic review from the AAP Regeneration Workshop.Growth and amelogenin-like factors in periodontal wound healing. A systematic review.Pre-clinical models for oral and periodontal reconstructive therapies.The use of enamel matrix derivative in the treatment of periodontal defects: a literature review and meta-analysis.Which reconstructive procedures are effective for treating the periodontal intraosseous defect?The relationship between baseline value and its change: problems in categorization and the proposal of a new method.Gene therapeutics for periodontal regenerative medicine.Craniofacial tissue engineering by stem cells.Clinical outcomes after treatment of periodontal intrabony defects with nanocrystalline hydroxyapatite (Ostim) or enamel matrix derivatives (Emdogain): a randomized controlled clinical trial.Periodontal regeneration with enamel matrix derivative in reconstructive periodontal therapy: a systematic review.Clinical performance of access flap surgery in the treatment of the intrabony defect. A systematic review and meta-analysis of randomized clinical trials.Minimally invasive periodontal therapy.Advanced reconstructive technologies for periodontal tissue repair.Enamel matrix protein derivatives: role in periodontal regeneration.Fundamental principles in periodontal plastic surgery and mucosal augmentation--a narrative review.Impact of cigarette smoking on clinical outcomes of periodontal flap surgical procedures: a systematic review and meta-analysis.Clinical concepts for regenerative therapy in intrabony defects.Tissue engineered periodontal products.Enamel matrix derivative and bone grafts for periodontal regeneration of intrabony defects. A systematic review and meta-analysis.Twenty years of enamel matrix derivative: the past, the present and the future.Amelogenin enhances the proliferation of cementoblast lineage cells.Five-year results of a prospective, randomized, controlled study evaluating treatment of intra-bony defects with a natural bone mineral and GTR.Five-year results following treatment of intrabony defects with enamel matrix proteins and guided tissue regeneration.

P2860

Q24240239-7DFC41DA-C64D-4430-890F-2289502D8C05 Q26770930-BD13A41C-1C66-4667-B45E-5E0895159F02 Q26778208-14BF2D59-B69A-43E3-9854-A1E9408EBEB9 Q26827153-EF059600-F389-49E5-9180-0D586239B04F Q30630933-2F998A35-F64F-4DFB-8EBB-07B70E8B0F29 Q30829331-3AED1BDA-FE30-4F95-A355-31B8ED7119C0 Q30843472-E7D36020-F699-45FB-AECB-41C1C98BD31B Q33214464-2F44133C-C28C-4875-AF36-8D18B5DBB484 Q33303470-79DAE527-6B53-474D-A111-63C57F8B51FA Q33308874-7A3E70F1-27B9-456A-BD48-EBAB1C7E6917 Q33814831-8E46EFD3-0737-4B8E-B42E-A8AECE0E3D29 Q33882978-5BCED682-27DC-4A7D-83AB-9B2179943C6C Q34076599-C89CAA1E-2037-4A59-B6DD-66D68DF19E36 Q34292337-1F436960-F787-4EBC-BAB6-F09C34D9253F Q34707043-5BC50C3F-FCF9-43FC-8653-6E22F28045C5 Q35024507-D753E699-AB87-455B-B12A-8CFD2B7F3A12 Q35145364-3AF315A1-854C-46C9-8016-D217FCB1761C Q35250376-E4B91AC5-7369-4C10-B417-29D0AE832F3F Q35670360-69DCA9A4-CA58-4269-9671-C80F65317C44 Q35866617-5F8412F6-2EC1-418E-8681-B0DAABBCB921 Q35969359-3035DCDA-F7B5-4093-933A-32E85ED39F98 Q36011890-CB584ACD-A82D-490C-9C6E-E81A04DD285C Q36209677-6E564BEC-DB7F-452A-87EF-A3D0D28DB6E7 Q36418370-2DBAD7D6-DD69-4C03-986D-51B2343ED214 Q36633835-20D4564B-FACF-49AE-A3F8-ACFF4BFC8F9D Q37599714-1264BAA3-44C4-497F-8A14-6480089E8945 Q37952322-7657CA20-0BF0-4B00-9BC4-232893B7557B Q37961036-DBBA9337-4440-4AA0-92B2-64E77CB53BD1 Q37988470-EB0DF143-E708-4CFA-890B-F880F253CB77 Q38002946-C333C982-9106-4E7B-8B27-5DA9B8598BA4 Q38106956-F0CDC43B-448D-46E4-837D-5F2D05F497AE Q38196874-EFF21249-C399-4790-9DB7-3841FA576A15 Q38258424-A6D3939D-066D-454C-B382-A198E9B52589 Q38418397-A5DB3B84-E023-49D4-8F1E-CB2FA95F3CFF Q38434125-2A4E90CB-485D-4CB6-8A1F-0D8F69D2A843 Q38501928-554398B6-2612-4882-9B64-34769B2F62D2 Q38778569-6F0E60D5-79AA-4B3B-BD30-842113C380D8 Q39559948-DB6E96D6-1459-42BE-BFBE-52EEFD636CEB Q42609756-D1D71530-F309-4B5E-85A7-973102DE01C4 Q42629143-84E61602-0BF9-417F-AE7E-418E7973891A

P2860

Enamel matrix proteins in the regenerative therapy of deep intrabony defects.

http://www.wikidata.org/entity/Q40645337

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

2002年论文

@zh

2002年论文

@zh-cn

name

Enamel matrix proteins in the regenerative therapy of deep intrabony defects.

@en

type

label

Enamel matrix proteins in the regenerative therapy of deep intrabony defects.

@en

prefLabel

Enamel matrix proteins in the regenerative therapy of deep intrabony defects.

@en

P1433

Q40645337-4566F9D9-D49D-4B09-8E34-BBFED3A27A28

P1476

Q40645337-502B69B3-3922-4DE3-801E-582A1D1B151B

P2093

Q40645337-35FE5824-8176-4974-9B98-6A70707DA5DB

Q40645337-3C89DE59-F64C-4D35-B7FD-18B568867C09

Q40645337-48337476-64DC-4979-9C8F-A7ED33A2D2A8

Q40645337-6C3A0B7F-E6BF-4885-8AD9-98BFDE0182CD

Q40645337-82A8F592-3F77-42B7-991E-3EDD77AC6DF2

Q40645337-8751241B-617B-4422-8E19-E75C9588A62C

Q40645337-982C0CF5-F179-4B74-8E1D-4DA97C86829C

Q40645337-A121E7C0-67BD-48BC-BF6A-6FC8E68CE406

Q40645337-A4202007-96F2-4A9B-A14B-3F596B75581D

Q40645337-AB06CD14-A31F-4689-A145-090C2605079E

P2860

Q40645337-078193AB-B36F-4721-8956-1F10FE77AA9F

Q40645337-0BCF5B7C-DC16-4472-9395-DFC441D0F9F0

Q40645337-49B8100D-B24B-435B-B706-97116A13FE11

Q40645337-4BC106CA-8755-479C-9363-38137F850B96

Q40645337-5C4574FC-15BF-417E-AEE9-0CC19E3E97FE

Q40645337-76554FF4-6742-4381-A3DB-759032ACF992

Q40645337-8594716D-A920-4BE3-B64B-209E5C85C074

Q40645337-8B19AA8D-1714-4A36-BE78-FFDD1E54BBA3

Q40645337-9738AA41-BE18-4804-871C-FC7955C8410A

Q40645337-9BF91EA5-A810-4B56-9422-866B70F46928

P304

Q40645337-CD6CDE2A-3EE0-460F-8C02-009279A3851F

P31

Q40645337-00394D2A-3B56-47A5-9EAE-F833CFA4CF7B

P356

Q40645337-D9B26A7A-E23D-40B2-AABD-30EBB4684156

P407

Q40645337-F0CB7783-623F-4FD3-9988-913500E0B314

P433

Q40645337-FE6CF19C-8F13-441B-80CC-85907F4083F0

P478

Q40645337-A89F07AC-7300-46B2-B29A-BFEF455E604B

P577

Q40645337-B7F816B0-8489-4B1F-8A65-D8B35F2D4ABD

P698

Q40645337-DCC105F3-3612-4441-BF74-83D7C110C6B0

P356

J.1600-051X.2002.290407.X

P1433

Journal of Clinical Periodontology

P1476

Enamel matrix proteins in the regenerative therapy of deep intrabony defects.

@en

P2093

Alberto Fonzar

http://www.w3.org/2001/XMLSchema#string

Beat Wallkamm

http://www.w3.org/2001/XMLSchema#string

Christine Tiedemann

http://www.w3.org/2001/XMLSchema#string

Dominik Dubravec

http://www.w3.org/2001/XMLSchema#string

Heinz Topoll

http://www.w3.org/2001/XMLSchema#string

Ioannis Fourmousis

http://www.w3.org/2001/XMLSchema#string

Jean E Suvan

http://www.w3.org/2001/XMLSchema#string

Lisa Mayfield

http://www.w3.org/2001/XMLSchema#string

Maurizio S Tonetti

http://www.w3.org/2001/XMLSchema#string

Maurizio Silvestri

http://www.w3.org/2001/XMLSchema#string

P2860

Growth factors in wound healing. Single and synergistic effects on partial thickness porcine skin wounds.

Focus on intrabony defects: guided tissue regeneration.

The treatment of intrabony defects with bone grafts.

Analysis of data from multiclinic trials.

Towards a cellular and molecular understanding of periodontics. Cementogenesis revisited.

Enamel matrix, cementum development and regeneration.

The use of barrier membranes and enamel matrix proteins in the treatment of angular bone defects. A prospective controlled clinical study.

Demonstration of enamel matrix proteins on root-analogue surfaces of rabbit permanent incisor teeth.

Guided tissue regeneration therapy of 203 consecutively treated intrabony defects using a bioabsorbable matrix barrier. Clinical and radiographic findings.

Generalizability of the added benefits of guided tissue regeneration in the treatment of deep intrabony defects. Evaluation in a multi-center randomized controlled clinical trial.

P304

317-325

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1034/J.1600-051X.2002.290407.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P577

2002-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11966929

http://www.w3.org/2001/XMLSchema#string